Inhibition of the cyclooxygenase/lipoxygenase pathways to improve interferon alfa efficacy in chronic hepatitis C: a wrong track.
Bastie
A
A
Castera
L
L
Roudot-Thoraval
F
F
Dhumeaux
D
D
Pawlotsky
J M
JM
D000998:Antiviral Agents / Q000627:therapeutic use*; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use*; D004357:Drug Synergism; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D016859:Lipoxygenase Inhibitors / Q000627:therapeutic use*
D000998:Antiviral Agents; D016861:Cyclooxygenase Inhibitors; D016898:Interferon-alpha; D016859:Lipoxygenase Inhibitors